SynthesisBMC cardiovascular disorders2025

Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: a meta-analysis.

Xiaoyan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.